PT Hetzer Medical Indonesia Tbk (ISX:MEDS) Long-Term Debt: Rp0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MEDS PT Hetzer Medical Indonesia Tbk ISX:MEDS
23 GF Score
Price Rp76.00
! 2 Warning Signs
View Full Analysis

What is PT Hetzer Medical Indonesia Tbk Long-Term Debt?

PT Hetzer Medical Indonesia Tbk ISX:MEDS +1.33% 23 Long-Term Debt is Rp0.00 Mil as of . 20. GuruFocus rates ISX:MEDS with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

PT Hetzer Medical Indonesia Tbk's Long-Term Debt for the quarter that ended in . 20 was Rp0.00 Mil.

PT Hetzer Medical Indonesia Tbk  (ISX:MEDS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

PT Hetzer Medical Indonesia Tbk Long-Term Debt Related Terms

PT Hetzer Medical Indonesia Tbk Long-Term Debt Historical Data

* Premium members only.

The historical data trend for PT Hetzer Medical Indonesia Tbk's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Hetzer Medical Indonesia Tbk Long-Term Debt Chart

PT Hetzer Medical Indonesia Tbk Annual Data
Trend
Long-Term Debt

PT Hetzer Medical Indonesia Tbk Semi-Annual Data
Long-Term Debt
ISX:MEDS
23GF Score
PT Hetzer Medical Indonesia Tbk ISX:MEDS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of Rp0.00 Mil mean?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a Long-Term Debt of Rp0.00 Mil as of . 20.
Is PT Hetzer Medical Indonesia Tbk's Long-Term Debt too high?
PT Hetzer Medical Indonesia Tbk's current Long-Term Debt is Rp0.00 Mil. Overall, PT Hetzer Medical Indonesia Tbk has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does PT Hetzer Medical Indonesia Tbk's Long-Term Debt compare to ISRG and BDX?
PT Hetzer Medical Indonesia Tbk's Long-Term Debt of Rp0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. PT Hetzer Medical Indonesia Tbk's current Long-Term Debt is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Hetzer Medical Indonesia Tbk stock overvalued right now?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a current Long-Term Debt of Rp0.00 Mil. The current Long-Term Debt is Rp0.00 Mil. PT Hetzer Medical Indonesia Tbk's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For PT Hetzer Medical Indonesia Tbk (ISX:MEDS), the current Long-Term Debt is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Hetzer Medical Indonesia Tbk Business Description

Address Jl. Mahar Martanegara No. 106, Kel. Cigugur Tengah, Kec. Cimahi Tengah, Provinsi Jawa Barat, Kota Cimahi, IDN, 40522
PT Hetzer Medical Indonesia Tbk is a pioneer in Indonesia which produces 4 Dimensional Ear Loop type health masks with the trademark Evo Plusmed.
23GF Score

Get the complete analysis for ISX:MEDS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp76.00
Price